DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Kopetz S, McDonough SL, Lenz HJ.
Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG 1406).
J Clin Oncol 2017
35. Abstract 520
Access:
We do not assume any responsibility for the contents of the web pages of other providers.